Pomerantz To Lead Lexicon Pharmaceuticals Securities Suit
By John Petrick ( June 4, 2019, 5:28 PM EDT) -- A Texas federal judge has ordered the Pomerantz Law Firm to serve as lead counsel in shareholders' proposed class action accusing Lexicon Pharmaceuticals of promising more than it could deliver in bringing its diabetes drug Zynquista to market....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.